Antigens, Differentiation, B-Lymphocyte
-
Subject Areas on Research
-
A frequent human CD20 (B1) differentiation antigen DNA polymorphism detected with MspI is located near 11q12-13.
-
A quantitative exploration of surface antigen expression in common B-cell malignancies using flow cytometry.
-
Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule.
-
Analysis of the expression of CD5 by human B cells and correlation with functional activity.
-
Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasms.
-
Anti-CD22 ligand-blocking antibody HB22.7 has independent lymphomacidal properties and augments the efficacy of 90Y-DOTA-peptide-Lym-1 in lymphoma xenografts.
-
Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes.
-
Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaques.
-
Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia.
-
B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.
-
B lymphocytes: how they develop and function.
-
Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502.
-
CD19 amplification of B lymphocyte Ca2+ responses: a role for Lyn sequestration in extinguishing negative regulation.
-
CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling.
-
CD19 and CD22 regulate a B lymphocyte signal transduction pathway that contributes to autoimmunity.
-
CD19 maps to a region of conservation between human chromosome 16 and mouse chromosome 7.
-
CD19 regulates intrinsic B lymphocyte signal transduction and activation through a novel mechanism of processive amplification.
-
CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction.
-
CD20: a regulator of cell-cycle progression of B lymphocytes.
-
CD22 cross-linking generates B-cell antigen receptor-independent signals that activate the JNK/SAPK signaling cascade.
-
CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux.
-
CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice.
-
CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor.
-
CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms.
-
CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.
-
CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex.
-
Cell proliferation is necessary for the determination of male fate in the gonad.
-
Characterization of an Epstein-Barr virus receptor on human epithelial cells.
-
Cloning of a complementary DNA encoding a new mouse B lymphocyte differentiation antigen, homologous to the human B1 (CD20) antigen, and localization of the gene to chromosome 19.
-
Development and distribution of a human B cell subpopulation identified by the HB-4 monoclonal antibody.
-
Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule.
-
Discontinuous expression of a membrane antigen (HB-7) during B lymphocyte differentiation.
-
Engagement of the adhesion receptor CD22 triggers a potent stimulatory signal for B cells and blocking CD22/CD22L interactions impairs T-cell proliferation.
-
Epstein-Barr virus-negative diffuse large B cell lymphoma with aberrant expression of CD3 and other T cell-associated antigens: report of three cases with a review of the literature.
-
Evaluation of lymphocyte differentiation in primary and secondary immunodeficiency diseases.
-
H2-DMalpha(-/-) mice show the importance of major histocompatibility complex-bound peptide in cardiac allograft rejection.
-
Heterogeneity in the B1 (CD20) cell surface molecule expressed by human B-lymphocytes.
-
Histiocytes in familial and infection-induced/idiopathic hemophagocytic syndromes may exhibit phenotypic differences.
-
Human anti-pneumococcal polysaccharide antibodies are secreted by the CD5- B cell lineage.
-
Hyper IgM syndrome associated with defective CD40-mediated B cell activation.
-
Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand.
-
Innate and adaptive receptors interact to balance humoral immunity.
-
Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19.
-
Involvement of p72syk kinase, p53/56lyn kinase and phosphatidyl inositol-3 kinase in signal transduction via the human B lymphocyte antigen CD22.
-
Isolation and structure of a cDNA encoding the B1 (CD20) cell-surface antigen of human B lymphocytes.
-
Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily.
-
Lupus-specific antiribonucleoprotein B cell tolerance in nonautoimmune mice is maintained by differentiation to B-1 and governed by B cell receptor signaling thresholds.
-
Macrophages (histiocytes) in various reactive and inflammatory conditions express different antigenic phenotypes.
-
Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop.
-
Mononuclear cells from patients with the hyper-IgE syndrome produce little IgE when they are stimulated with recombinant human interleukin-4.
-
Phosphorylation of the B1 (CD20) molecule by normal and malignant human B lymphocytes.
-
Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody.
-
Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion.
-
Severely impaired B lymphocyte proliferation, survival, and induction of the c-Myc:Cullin 1 ubiquitin ligase pathway resulting from CD22 deficiency on the C57BL/6 genetic background.
-
Structure and domain organization of the CD19 antigen of human, mouse, and guinea pig B lymphocytes. Conservation of the extensive cytoplasmic domain.
-
Structure of the gene encoding the human B lymphocyte differentiation antigen CD20 (B1).
-
Structure of the genes encoding the CD19 antigen of human and mouse B lymphocytes.
-
Surface-expressed invariant chain (CD74) is required for internalization of human leucocyte antigen-DR molecules to early endosomal compartments.
-
T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice.
-
The B cell surface molecule B1 is functionally linked with B cell activation and differentiation.
-
The B lymphocyte surface antigen CD75 is not an alpha-2,6-sialyltransferase but is a carbohydrate antigen, the production of which requires the enzyme.
-
The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13.
-
The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system.
-
The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.
-
The CD19/CD21 signal transduction complex of B lymphocytes.
-
The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma.
-
The gene that encodes the human CD20 (B1) differentiation antigen is located on chromosome 11 near the t(11;14)(q13;q32) translocation site.
-
The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes.
-
Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development.
-
Transfection of the CD20 cell surface molecule into ectopic cell types generates a Ca2+ conductance found constitutively in B lymphocytes.
-
Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway.